Abatacept has beneficial effects in rheumatoid arthritis patients with an inadequate response to anti-TNF alpha therapy

Authors
Category Primary study
JournalClinical and experimental rheumatology
Year 2005

This article is included in 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
  • ATTAIN [Abatacept Trial in Treatment of Anti-TNF INadequate responders] (15 documents)
Loading references information
This article has no abstract
Epistemonikos ID: 424427955a8c247541366df0acb28f3d4ee0fa7b
First added on: Oct 26, 2017